Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,883 | 213 | 98.7% |
| Education | $38.03 | 8 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $435.11 | 26 | $0 (2019) |
| Novo Nordisk Inc | $382.22 | 46 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $318.22 | 19 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $245.18 | 19 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $225.12 | 18 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $185.97 | 16 | $0 (2018) |
| GlaxoSmithKline, LLC. | $159.73 | 14 | $0 (2018) |
| Lilly USA, LLC | $142.04 | 10 | $0 (2022) |
| Allergan Inc. | $141.35 | 10 | $0 (2018) |
| Amgen Inc. | $140.59 | 10 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $55.29 | 2 | ABBVIE INC. ($29.00) |
| 2022 | $18.07 | 1 | Lilly USA, LLC ($18.07) |
| 2020 | $33.55 | 2 | Novo Nordisk Inc ($19.91) |
| 2019 | $67.12 | 4 | Novo Nordisk Inc ($30.49) |
| 2018 | $1,097 | 86 | Novo Nordisk Inc ($199.94) |
| 2017 | $1,650 | 126 | Boehringer Ingelheim Pharmaceuticals, Inc. ($242.29) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/08/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: ONCOLOGY | ||||||
| 02/26/2024 | Boston Scientific Corporation | Intracept (Device) | Food and Beverage | Cash or cash equivalent | $26.29 | General |
| Category: Pain | ||||||
| 08/15/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Diabetes | ||||||
| 02/21/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/03/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Diabetes | ||||||
| 08/26/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE, PRAXBIND | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/19/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: Diabetes | ||||||
| 04/29/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/25/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Diabetes | ||||||
| 11/29/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/10/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $5.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Education | In-kind items and services | $4.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/10/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Diabetes | ||||||
| 09/10/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $1.63 | General |
| Category: Diabetes | ||||||
| 08/30/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/27/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/24/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes | ||||||
| 08/20/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Diabetes | ||||||
| 08/20/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $1.46 | General |
| Category: Diabetes | ||||||
| 08/15/2018 | Lilly USA, LLC | FORTEO (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Bone Muscle Joint | ||||||
| 08/13/2018 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.02 | General |
| 08/10/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: RESPIRATORY | ||||||
| 08/09/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE, PRAXBIND | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/02/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Diabetes | ||||||
| 08/02/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $1.73 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,092 | 1,247 | $373,731 | $118,219 |
| 2022 | 14 | 1,185 | 1,464 | $419,537 | $127,283 |
| 2021 | 16 | 1,773 | 2,232 | $592,369 | $190,831 |
| 2020 | 16 | 1,655 | 2,094 | $434,568 | $139,569 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 336 | 336 | $124,992 | $43,152 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 236 | 340 | $125,120 | $28,661 | 22.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 84 | 84 | $38,136 | $23,676 | 62.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 181 | 225 | $58,500 | $12,689 | 21.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 15 | $11,940 | $3,188 | 26.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 84 | 84 | $3,780 | $2,576 | 68.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 43 | $1,375 | $1,286 | 93.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 42 | 43 | $1,290 | $936.03 | 72.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 12 | $4,392 | $893.99 | 20.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 17 | $2,550 | $707.03 | 27.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 28 | 30 | $900.00 | $285.60 | 31.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 18 | $756.00 | $167.32 | 22.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 383 | 383 | $133,667 | $50,874 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 260 | 450 | $153,450 | $37,677 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 265 | 335 | $81,070 | $18,420 | 22.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 23 | 23 | $10,442 | $6,353 | 60.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 19 | 21 | $11,550 | $3,354 | 29.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 14 | 14 | $10,374 | $3,171 | 30.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 20 | 22 | $7,502 | $2,286 | 30.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 46 | 46 | $1,380 | $1,380 | 100.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 33 | 33 | $1,485 | $999.22 | 67.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 46 | 46 | $1,380 | $966.22 | 70.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 23 | 26 | $3,666 | $947.23 | 25.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 11 | 19 | $2,071 | $443.28 | 21.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 27 | 31 | $930.00 | $296.13 | 31.8% |
About Dr. Daniel Yang, MD
Dr. Daniel Yang, MD is a Internal Medicine healthcare provider based in Spokane, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649372756.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Yang, MD has received a total of $2,921 in payments from pharmaceutical and medical device companies, with $55.29 received in 2024. These payments were reported across 221 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,883).
As a Medicare-enrolled provider, Yang has provided services to 5,705 Medicare beneficiaries, totaling 7,037 services with total Medicare billing of $575,903. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Spokane, WA
- Active Since 09/01/2006
- Last Updated 07/21/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1649372756
Products in Payments
- Victoza (Drug) $244.95
- FARXIGA (Drug) $196.16
- XARELTO (Drug) $191.08
- PRADAXA (Drug) $141.61
- JANUVIA (Drug) $135.03
- TOUJEO (Drug) $125.72
- SYMBICORT (Drug) $117.06
- Ozempic (Drug) $116.82
- JARDIANCE (Drug) $103.14
- TRADJENTA (Drug) $99.88
- Prolia (Biological) $99.56
- SOLIQUA (Drug) $99.40
- NUEDEXTA (Drug) $88.42
- XIFAXAN (Drug) $79.39
- HYSINGLA ER (Drug) $67.43
- TRULICITY (Drug) $67.13
- NAMZARIC (Drug) $61.81
- BREO (Drug) $57.81
- INVOKANA (Drug) $54.10
- STIOLTO (Drug) $52.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Spokane
Katherine Tuttle, Md, MD
Internal Medicine — Payments: $450,232
Jessica Craddock, Md, MD
Internal Medicine — Payments: $344,643
Dr. Radica Alicic, M.d, M.D
Internal Medicine — Payments: $50,393
James Mudd, M.d, M.D
Internal Medicine — Payments: $30,546
Dr. Rachel Safran, M.d, M.D
Internal Medicine — Payments: $17,911
Dr. Usman Ajaz, M.d, M.D
Internal Medicine — Payments: $9,648